FDA & Prescription Drugs
Actos Drug May Increase Risk of Bladder Cancer
Actos (pioglitazaone) has recently been associated with the risk of bladder cancer, according to the FDA. On August 4, 2011, the FDA approved updated drug labels for the pioglitazone-containing…